B. Wettermark

Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment

L. Brandt, H. Kieler, R. Bodén, 2014, International journal of clinical practice.

Potential savings without compromising the quality of care

F. Granath, B. Godman, R. Zarrinkoub, 2009, International journal of clinical practice.

Educational intervention on medication reviews aiming to reduce acute healthcare consumption in elderly patients with potentially inappropriate medicines—A pragmatic open‐label cluster‐randomized controlled trial in primary care

B. Wettermark, M. Andersen, K. Schmidt-Mende, 2017, Pharmacoepidemiology and drug safety.

General practitioners’ and nurses’ views on medication reviews and potentially inappropriate medicines in elderly patients – a qualitative study of reports by educating pharmacists

B. Wettermark, M. Andersen, K. Schmidt-Mende, 2018, Scandinavian journal of primary health care.

Selection bias in pharmacy‐based patient surveys

P. Frisk, S. Kälvemark-Sporrong, B. Wettermark, 2014, Pharmacoepidemiology and drug safety.

Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries

R. Malmström, M. Bennie, B. Godman, 2013, International journal of clinical practice.